12059749 · Active · incorporated 7 years, 1 month ago · Oxfordshire
Biotech AI Biotech & Life Sciences Drug Discovery Generative AI Series B+
Etcembly uses AI and bioengineering to accelerate therapeutic innovation and design next-generation biologics, focusing on T Cell Receptor discovery.
See the complete cap table with every shareholder, founder tags, dilution across 22 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.